Novo-Nordisk Inc

General

Total Cases97

Active Cases5

Patents1,187

CourtsD. Delaware D. New Jersey S.D. New York

TypeOperating Company

Elite Ratings

--

novonordisk.com

Ratings

Experience

Grade

Trend

DCT

L3

E

PTAB

L4

A

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
12/13/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2; 10,335,462 B2; 8,129,343 B2; 8,920,383 B2; 9,457,154 B2; 9,775,953 B2. (Attachments: # [1] Stipulation of Dismissal) (mws) (Entered: 12/13/2024)
12/13/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2; 10,335,462 B2; 8,129,343 B2; 8,920,383 B2; 9,457,154 B2; 9,775,953 B2. (Attachments: # [1] Stipulation of Dismissal) (mws) (Entered: 12/13/2024)
12/13/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024) SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024)
12/13/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024) SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024)
12/13/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	Remark: CASE CLOSED per [371] STIPULATION of Dismissal, as all defendants in the case have been terminated. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC (mws) (Entered: 12/13/2024)
12/13/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	Remark: CASE CLOSED per [371] STIPULATION of Dismissal, as all defendants in the case have been terminated. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC (mws) (Entered: 12/13/2024)
12/12/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	STIPULATION of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences by Novo Nordisk Inc., Novo Nordisk A/S. (Egan, Brian) (Entered: 12/12/2024)
12/12/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	STIPULATION of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences by Novo Nordisk Inc., Novo Nordisk A/S. (Egan, Brian) (Entered: 12/12/2024)
12/06/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	SO ORDERED, re (369 in 1:22-cv-00294-CFC-EGT, 420 in 1:22-md-03038-CFC-EGT) MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 12/06/2024)
12/06/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	SO ORDERED, re (369 in 1:22-cv-00294-CFC-EGT, 420 in 1:22-md-03038-CFC-EGT) MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 12/06/2024)